MDMA for the Treatment of Negative Symptoms in Schizophrenia

The profound economic burden of schizophrenia is due, in part, to the negative symptoms of the disease, which can severely limit daily functioning. There is much debate in the field regarding their measurement and classification and there are no FDA-approved treatments for negative symptoms despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnovitz, Mitchell D., Spitzberg, Andrew J., Davani, Ashkhan J., Vadhan, Nehal P., Holland, Julie, Kane, John M., Michaels, Timothy I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225098/
https://www.ncbi.nlm.nih.gov/pubmed/35743326
http://dx.doi.org/10.3390/jcm11123255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225098/
https://www.ncbi.nlm.nih.gov/pubmed/35743326
http://dx.doi.org/10.3390/jcm11123255

Ejemplares similares